San Francisco Pilot Brings Same-Day Injectable Buprenorphine Closer to People Experiencing Homelessness

A new $500,000 San Francisco pilot is designed to reduce delays between requesting opioid-use-disorder treatment and receiving long-acting injectable buprenorphine. The program will begin at the Maria X. Martinez Health Resource Center and could expand to five additional clinics.

The San Francisco Department of Public Health building at 101 Grove Street in San Francisco.
The San Francisco Department of Public Health building at 101 Grove Street in San Francisco.

San Francisco has launched a $500,000 pilot intended to remove several of the practical barriers that can prevent people from beginning medication treatment for opioid use disorder.

The On Demand Direct-to-Inject Pilot operates through the Maria X. Martinez Health Resource Center, which serves many people experiencing homelessness and other obstacles to conventional healthcare. Clinically eligible patients may be able to receive an initial dose of long-acting injectable buprenorphine during the same visit in which treatment is requested.

This does not mean that every person who walks into the clinic will automatically receive medication. Patients must still receive a clinical assessment, meet eligibility requirements and participate in an appropriate treatment plan. The important change is that eligible patients may no longer have to complete several separate appointments before receiving their first injection.

According to information released by San Francisco public-health officials, the pilot will fund approximately 460 starting doses and 500 follow-up doses through April 2028. Funding also supports secure medication storage and tracking systems. The city may expand the model to as many as five additional clinics during 2027.

Long-acting injectable buprenorphine can provide medication coverage for a week or a month, depending on the product and treatment plan. This can be especially significant for people who lack reliable transportation, stable housing, secure medication storage or the ability to visit a pharmacy every day.

The pilot also reflects a larger movement toward low-barrier treatment. Traditional systems sometimes require a person to complete multiple assessments, referrals, pharmacy visits or periods of withdrawal before medication begins. Every additional step creates another opportunity for someone to disengage from care or return to a dangerous drug supply.

San Francisco plans to evaluate treatment retention, patient engagement, overdoses, emergency-department visits and hospitalizations. Those outcomes will matter more than the number of initial injections alone. A successful program must help people remain connected to treatment and recovery support after the first dose.

The program is supported primarily through San Francisco’s Breaking the Cycle Fund, a public-private initiative connected to homelessness and behavioral-health services.

People interested in the program should contact the clinic directly. Same-day access remains subject to medical assessment, medication availability and clinical eligibility.

Why This Matters

A person’s willingness to begin treatment can be brief and difficult to recreate. Systems that ask someone to return days later, visit another office or navigate an unfamiliar pharmacy risk losing that opportunity. Same-day medication access attempts to make the healthcare system respond when the individual is ready. The pilot is particularly relevant for people experiencing homelessness, who may face transportation, communication and medication-storage barriers that conventional treatment models were not designed to accommodate.

Addiction Recovery Pro Perspective

Addiction Recovery Pro views the most promising part of this pilot as the effort to connect urgency with continuity. Starting medication quickly is important, but recovery does not end with an injection. Effective implementation should connect patients with ongoing medical care, counseling when appropriate, housing assistance, peer support and a realistic plan for follow-up. ARP also believes the public deserves transparent reporting on retention, patient experience and subsequent treatment access—not simply the number of doses administered.

WHAT THIS MEANS TO THE WORLD OF RECOVERY: If San Francisco demonstrates that same-day injectable treatment improves retention and reduces medical emergencies, similar models could be considered by street-medicine teams, emergency departments, shelters and community clinics elsewhere. The broader lesson is that treatment systems should reduce unnecessary waiting without lowering clinical safety. Recovery services work best when medication, human connection and long-term support are available as parts of the same pathway.

Treatment options in this location

Explore addiction treatment options in San Francisco, California.

Original sources

Explore Treatment and Recovery Resources

Search licensed treatment facilities and recovery support by state and city.

Explore Treatment and Recovery Resources

Addiction Recovery Pro provides educational and informational resources. This article is not medical advice, diagnosis, treatment, legal advice or emergency assistance. Information may change after publication. Consult qualified professionals and original sources when making health, legal or treatment decisions.